Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
<i>Background</i>. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Ou...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2023-08-01
|
| Serie: | Medicina |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/1648-9144/59/9/1560 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|